6th Theranostics World Congress


24. - 26. Juni 2022

RheinMain CongressCenter (RMCC) in WiesbadenLink zum ProgrammLink zur Anmeldungin Kalender übernehmen


Kongress- und Kulturmanagement GmbH

Wissenschaftliche Leitung:
Professor Dr. Richard P. Baum

Anmeldung / Organisation

6th Theranostics World Congress
c/o Kongress- und Kulturmanagement GmbH
Rießnerstraße 12B
99427 Weimar

Kontakt: Tina Streitberger
Telefon: 49 3643 2468-169
E-Mail: twc2022@kukm.de



RheinMain CongressCenter (RMCC)
Friedrich-Ebert-Allee 1
65185 Wiesbaden
Physik und Technik, Uroradiologie/Urogenitaldiagnostik, Onkologische Bildgebung, CT, PET, Hybridbildgebung (PET-MR, PET-CT)
Fachärzte, Ärzte in Weiterbildung (AiW), Studenten, Ingenieure / Naturwiss.
Weitere Infos
The TWC 2022 will be a hybrid event, enabling you to attend in-person or online. We want to take a 360° view on the wide field of Theranostics in Radiomolecular Precision Oncology. Some of the topics this year are: Radioisotope Production and Distribution – What is the Future? ▪ Radiochemistry and Radiopharmacy – New Developmentsrn▪ Neuroendocrine Tumors ▪ Prostate Cancer ▪ Novel/other indications/Genetics ▪ Medical Physics/Dosimetry/AI/Instrumentation ▪ FAP, Radioprotectors, Radiosensitizers ▪ Patient Forum/Round Table Discussion.2022 is also the year for the celebration of 25 years of Peptide Receptor Radionuclide Therapy (PRRT) in Germany which started in Frankfurt/Main in 1997. There is certainly a lot to discuss and celebrate! Therefore, it's our great pleasure to welcome you to the 6th Theranostic World Congress from June 24 – 26, 2022, in Wiesbaden, Germany.

Abstract submission

The abstract submission is opened till April 15th, 2022. Abstracts can be submitted for one of the following topics:

Advances in Radiochemistry & Radioisotope Production
▪ Novel isotope production strategies
▪ New radiolabeling approaches
▪ Isotope supply
▪ Advances in chelator chemistry

Clinical Applications
▪ Theranostics for PCa & NET
▪ FAP inhibitors
▪ Novel indications (Adeno-CAs, Sarcomas)

Highlights in Preclinical R&D
▪ New targets and interesting vectors
▪ Strategies for PK improvement (e.g., albumin binders)
▪ Pre-targeting approaches
▪ Multi-modal theranostics

Nuclear Medicine meets Genetics
▪ Genetic reasons for (non)responding


If the abstract is accepted, presenters must register for the congress and pay the registration fee by 31 May 2022. All accepted abstracts will be presented as posters. A limited number of abstracts will be selected for oral presentations.


Onsite participation | Regular Congress fee


Onsite participation | Fellows Fee


Onsite participation | Patients


Online participation


Alle genannten Preise in Euro, sofern nicht anders angegeben.